Virology Research Epstein-Barr virus’s new approach for causing diseases By Editor's Desk 29 May 2024 90% of the adult population is infected with EBV, which often causes no symptoms or sickness.
Business CDMO Healthcare & Pharmaceuticals News Samsung Biologics Q3 2026 Results: Plant 5 Ramp-Up and Rockville Lift Revenue to KRW 1,490 Billion as 2026 Guidance Rises to 20% 21 October 202622 October 2026 BiotechReality Business Intelligence Desk
Clinical Data Healthcare & Pharmaceuticals News Amgen and AstraZeneca Report TEZSPIRE Eosinophilic Esophagitis Phase 3 CROSSING Results 20 October 202620 October 2026 Clinical Trials & Data Desk
Business Healthcare & Pharmaceuticals Merger & Acquisitions News Merck KGaA Announces Silence Therapeutics Acquisition to Add Divesiran siRNA Therapy to Rare Disease Pipeline 19 October 202620 October 2026 BiotechReality Business Intelligence Desk
Clinical Data Healthcare & Pharmaceuticals News Oncology MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan 17 October 202617 October 2026 Clinical Trials & Data Desk
Regulatory Approval Healthcare & Pharmaceuticals News Oncology Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types 16 October 202617 October 2026 Clinical Trials & Data Desk
Clinical Data Healthcare & Pharmaceuticals News Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year 15 October 202615 October 2026 Clinical Trials & Data Desk